Australia's largest stock trading and investment forum Australia's #1 stock forum

OPY

Click for more information

0.00%

19.5¢ openpay group ltd

Ann: Voulntary suspension, page-116

First 116 Last

Share
Profile

Follow
prosperity

9,255 Posts.

893

08/02/23

09:29

Post #: 66129755
Share

Originally posted by mrspeculator: ↑

The answer John1933 seems to rest with A H Meydan. He's the primary creditor and director. If you follow the dots carefully, OPY issued the quarterly report and Appendix 4C AFTER market Jan 31, so nobody could trade out. They sensed it was a bad report card. Meydan would have made a call stating he was no longer committing to further funds due to what appeared to be rolling quarters of high cash burn. Shareholders never stood a chance. Last Tuesday 1600 AEDST was the final chance to get out. The trading halt early next morning was more a coffin-sealing ceremony rather than a chance to exit with some dignity.
They thought they had further funding until the financier stopped buying their Disallowed.
It's only ever been a disaster, better seen in hindsight rather than from its lofty highs.

Expand

Disallowed burns bad.
Lots of shareholders would be feeling it.

OPY Price at posting: 19.5¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 21 more messages in this thread...

First 116 Last

Add OPY (ASX) to my watchlist